|
rs3816587 |
SNP |
PedAM |
snpId=rs3816587; pubmedId=17554300; geneId=29945; geneSymbol=ANAPC4; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.]; score=0.002367032; Year=2007; geneSymbol_dbSNP=ANAPC4; CHROMOSOME=4; POS=25415622; REF=C; ALT=T |
details
|
|
|
rs3824660 |
SNP |
PedAM |
snpId=rs3824660; pubmedId=24390342; geneId=2625; geneSymbol=GATA3; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Genetics of rheumatoid arthritis contributes to biology and drug discovery.; score=0.240542884; Year=2013; geneSymbol_dbSNP=GATA3; CHROMOSOME=10; POS=8062759; REF=C; ALT=T |
details
|
|
|
rs3825807 |
SNP |
PedAM |
snpId=rs3825807; pubmedId=24795506; geneId=1909; geneSymbol=EDNRA; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Our results do not confirm association between ABO rs579459, PPAP2B rs17114036, ADAMTS7 rs3825807, PIK3CG rs17398575, and EDNRA rs1878406 and subclinical atherosclerosis and CV disease in RA.; score=0.000814326; Year=2014; geneSymbol_dbSNP=ADAMTS7; CHROMOSOME=15; POS=78796769; REF=A; ALT=G |
details
|
|
|
rs3853839 |
SNP |
PedAM |
snpId=rs3853839; pubmedId=21179534; geneId=51284; geneSymbol=TLR7; diseaseId=umls:C0003873; sourceId=BeFree; sentence=In the discovery phase of the study we found a significant association of SNPs rs2072493 in TLR5 and rs3853839 in TLR7 with RA disease susceptibility.; score=0.002638474; Year=2010; geneSymbol_dbSNP=TLR7; CHROMOSOME=X; POS=12889539; REF=C; ALT=G |
details
|
|
|
rs3853839 |
SNP |
PedAM |
snpId=rs3853839; pubmedId=21179534; geneId=7100; geneSymbol=TLR5; diseaseId=umls:C0003873; sourceId=BeFree; sentence=In the discovery phase of the study we found a significant association of SNPs rs2072493 in TLR5 and rs3853839 in TLR7 with RA disease susceptibility.; score=0.003181358; Year=2010; geneSymbol_dbSNP=TLR7; CHROMOSOME=X; POS=12889539; REF=C; ALT=G |
details
|
|
|
rs386493716 |
SNP |
PedAM |
snpId=rs386493716; pubmedId=21267572; geneId=7515; geneSymbol=XRCC1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Rheumatoid arthritis risk associates with DNA repair gene XRCC1 Arg399Gln polymorphism in Turkish patients.; score=0.005905708; Year=2012; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs386502799 |
SNP |
PedAM |
snpId=rs386502799; pubmedId=18180278; geneId=114609; geneSymbol=TIRAP; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The Mal S180L and TLR4 G299D polymorphisms do not contribute to RA susceptibility or severity either individually or in combination.; score=0.000542884; Year=2008; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs386514057 |
SNP |
PedAM |
snpId=rs386514057; pubmedId=15457444; geneId=471; geneSymbol=ATIC; diseaseId=umls:C0003873; sourceId=BeFree; sentence=We investigated the contribution of common genetic polymorphisms in RFC-1 (G80A), ATIC (C347G), and TS (28-bp tandem repeats located in the TS enhancer region [TSER*2/*3]) and of MTXPGs to the effect of MTX in patients with rheumatoid arthritis.; score=0.137197984; Year=2004; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs386514057 |
SNP |
PedAM |
snpId=rs386514057; pubmedId=15564880; geneId=8836; geneSymbol=GGH; diseaseId=umls:C0003873; sourceId=BeFree; sentence=We investigated whether polymorphisms in reduced folate carrier (SLC19A1 G80A) and gamma-glutamyl-hydrolase (GGH-401C/T) are predictive of methotrexate polyglutamate (MTXPG) levels in patients with rheumatoid arthritis treated with weekly low-dose methotrexate (MTX).; score=0.130011012; Year=2004; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs386514057 |
SNP |
PedAM |
snpId=rs386514057; pubmedId=22971639; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The results of this study suggest that the RFC1 G80A polymorphism may be a useful marker for predicting MTX efficacy in Japanese patients with RA.; score=0.019998279; Year=2014; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs386514057 |
SNP |
PedAM |
snpId=rs386514057; pubmedId=24350725; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The aim of our study was to characterize the association of clinicopathological variables and the SLC19A1/RFC-1 G80A polymorphism in methotrexate (MTX)-related toxicity in Portuguese patients with rheumatoid arthritis.; score=0.019998279; Year=2015; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs386514057 |
SNP |
PedAM |
snpId=rs386514057; pubmedId=17965559; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Frequencies of MTHFR C677T and A1298C were similar to those reported in Japanese RA patients, while frequencies of RFC-1 G80A genotypes differed from those reported in RA patients in the United States.; score=0.019998279; Year=2007; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs386514057 |
SNP |
PedAM |
snpId=rs386514057; pubmedId=15564880; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=We investigated whether polymorphisms in reduced folate carrier (SLC19A1 G80A) and gamma-glutamyl-hydrolase (GGH-401C/T) are predictive of methotrexate polyglutamate (MTXPG) levels in patients with rheumatoid arthritis treated with weekly low-dose methotrexate (MTX).; score=0.019998279; Year=2004; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs386514057 |
SNP |
PedAM |
snpId=rs386514057; pubmedId=15457444; geneId=6573; geneSymbol=SLC19A1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=We investigated the contribution of common genetic polymorphisms in RFC-1 (G80A), ATIC (C347G), and TS (28-bp tandem repeats located in the TS enhancer region [TSER*2/*3]) and of MTXPGs to the effect of MTX in patients with rheumatoid arthritis.; score=0.019998279; Year=2004; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs386580289 |
SNP |
PedAM |
snpId=rs386580289; pubmedId=16142856; geneId=3950; geneSymbol=LECT2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Association of chondromodulin-II Val58Ile polymorphism with radiographic joint destruction in rheumatoid arthritis.; score=0.000271442; Year=2005; geneSymbol_dbSNP=NA; CHROMOSOME=NA; POS=NA; REF=NA; ALT=NA |
details
|
|
|
rs3890745 |
SNP |
PedAM |
snpId=rs3890745; pubmedId=18794853; geneId=79258; geneSymbol=MMEL1; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Common variants at CD40 and other loci confer risk of rheumatoid arthritis.; score=0.250282454; Year=2008; geneSymbol_dbSNP=MMEL1; CHROMOSOME=1; POS=2622185; REF=T; ALT=C |
details
|
|
|
rs3890745 |
SNP |
PedAM |
snpId=rs3890745; pubmedId=20453842; geneId=79258; geneSymbol=MMEL1; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.]; score=0.250282454; Year=2010; geneSymbol_dbSNP=MMEL1; CHROMOSOME=1; POS=2622185; REF=T; ALT=C |
details
|
|
|
rs3890745 |
SNP |
PedAM |
snpId=rs3890745; pubmedId=18794853; geneId=79258; geneSymbol=MMEL1; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Common variants at CD40 and other loci confer risk of rheumatoid arthritis.]; score=0.250282454; Year=2008; geneSymbol_dbSNP=MMEL1; CHROMOSOME=1; POS=2622185; REF=T; ALT=C |
details
|
|
|
rs3890745 |
SNP |
PedAM |
snpId=rs3890745; pubmedId=24449572; geneId=79258; geneSymbol=MMEL1; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study.; score=0.250282454; Year=2013; geneSymbol_dbSNP=MMEL1; CHROMOSOME=1; POS=2622185; REF=T; ALT=C |
details
|
|
|
rs3911238 |
SNP |
PedAM |
snpId=rs3911238; pubmedId=25150077; geneId=1421; geneSymbol=CRYGD; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Among these SNPs, the ITGAV-rs3911238-G/C polymorphism was associated with RA disease activity [remission-to-low and moderate-to-high in codominant model (CC vs.GG: OR=1.53, p=0.041 and allele (C vs. G: OR=1.18, p=0.042)] and presence of anti-CCP (codominant CC vs.GG: OR=2.77, p=0.001, allele C vs. G: OR=1.19,p=0.033).; score=0.021986792; Year=2013; geneSymbol_dbSNP=ITGAV; CHROMOSOME=2; POS=186605617; REF=G; ALT=C |
details
|
|
